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Abstract Tubulin of Giardia lamblia, a representative of the 
oldest eukaryotes, was screened for posttranslational modifica-
tions. Mass spectrometry of the carboxy-terminal peptides 
documents a large number of variants. Both a- and ß-tubulin 
show polyglycylation with up to 20 and 15 extra glycyl residues 
respectively. Minor variants show a low level of glutamylation 
without or with glycylation. The glutamylation-specific antibody 
GT335 detects a- and ß-tubulin in immunoblots. The terminal 
tyrosine is fully retained in cc-tubulin, which is completely 
acetylated at Lys-40. Thus except for the detyrosination/ 
tyrosination cycle all posttranslational modifications known for 
higher eukaryotes are already present in Giardia. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
The structural unit of microtubules is the αβ tubulin heter-
odimer which is usually encoded by small multigene families 
for both a- and ß-tubulin. Tubulins are subject to a number 
of posttranslational modifications. Some oc-tubulins are acety-
lated at Lys-40 [1] and certain ß-tubulin isotypes show phos-
phorylation of a serine in the carboxy-terminal region [2-4]. 
In addition there is a set of posttranslational modifications 
which seems restricted to tubulins. Certain oc-tubulins show 
a cycle for the carboxy-terminal tyrosine based on a carboxy-
peptidase activity and a re-addition due to tubulin-tyrosine 
ligase [5]. The latter enzyme has been purified and cloned 
from mammalian brain [6]. Fur ther excision involving the 
penultimate glutamyl residue leads to a tubulin which is no 
longer a substrate for the ligase [7,8]. Two modifications are 
common to a- and ß-tubulin. Polyglutamylation [9] and poly-
glycylation [10] involve the addition of several residues to the 
γ-carboxyl group of a glutamyl residue located within the 
carboxy-terminal 12 residues. Thus all tubulin-specific modi-
fications involve the carboxy-terminal region which is usually 
rather acidic in nature. Polyglycylation has so far been docu-
mented only for axonemal microtubules of cilia and flagella. 
Although found in protists such as Paramecium [10] and Giar-
dia [11], in sperm of sea urchins [12-14] and bull [15,16] it is 
conspicuously absent from Trypanosoma [17]. 
Molecular phylogenies covering ribosomal R N A [18], actin 
[19], a-tubulin [20] as well as the elongation factors l a and 2 
[21] all show that diplomonads like Giardia lamblia probably 
reflect the oldest branch of the eukaryotic tree. Giardia has 
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eight flagellar axonemes and a large disc consisting of micro-
tubules and microribbons [22,23]. Thus cytoskeletons of Giar-
dia can be used to decide which posttranslational modifica-
tions of tubulin are already present in an ancient eukaryote. 
Here we show that Giardia lamblia has almost the entire com-
plement of tubulin-specific modifications. We discuss that 
polyglutamylation is a widespread tubulin modification while 
polyglycylation is restricted to some but not all axonemal 
microtubules. 
2. Materials and methods 
2.1. Cells, cytoskeletal preparations and tubulin isolation 
Giardia culture, detergent extraction with 0.5% Triton X-100 and 
SDS-PAGE of the resulting cytoskeletal preparation were as described 
[11]. After staining with Coomassie brilliant blue the dominant tubu-
lin band corresponding to a- and ß-tubulins was excised, briefly 
washed with water and frozen at —70°C until use. 
2.2. Isolation and characterization of the carboxy-terminal peptides 
The carboxy-terminal peptides of ß-tubulin were isolated from a 
CNBr digest. Stained gel fragments containing tubulin were processed 
for in situ CNBr treatment [15]. After lyophilization the digest was 
recovered in buffer A (20 mM Tris-HCl, pH 8) by a SMART fast 
desalting column and separated on a TSK gel DEAE-NPR column 
(Tosohaas, Stuttgart, Germany) as described [10]. The column dimen-
sions were 4.6X35 mm. The flow rate was 500 μΐ/min and fractions of 
200 μΐ were collected. The elution profile was monitored by absorp-
tion at 214 nm. Appropriate fractions of the acidic peptides were 
processed by reverse-phase HPLC on a Vydac 218 TP 51 column as 
described [11]. The carboxy-terminal peptides of a-tubulin were iso-
lated from a digest with endoproteinase LysC and processed through 
Mono Q and HPLC [11]. 
All peak fractions from the HPLC runs were characterized by mass 
spectra recorded with a Kratos MALDI 3 or 4 time of flight mass 
spectrometer (Shimadzu, Duisburg, Germany). The matrix was a-cy-
апо-4-hydroxycinnamic acid in 30% acetonitrile, 0.06%o TFA. Spectra 
were recorded in the linear negative mode. Calibration was with bo-
vine insulin, α-melanocyte stimulating hormone and synthetic pepti-
des. Major peptide peaks were analyzed by automated Edman degra-
dation using instruments with on-line phenylthiohydantoin amino 
acid analysis. 
The carboxy-terminal sequence of the unmodified ß-tubulin peptide 
was obtained by carboxypeptide digestion monitored by mass spec-
trometry using conditions similar to those given by Bonetto et al. [24]. 
Digestion was in 50 mM sodium citrate buffer, 10% acetonitrile, pH 
5.5 with 0.4 μg carboxypeptidase Y (Boehringer, Mannheim, Ger-
many) in 7 μΐ at room temperature. Aliquots removed after 30, 60, 
130 and 230 min were subjected to mass spectrometry. 
2.3. Acetylation of Lys-40 in a-tubulin 
An aliquot of a cytoskeletal preparation was subjected to SDS-
PAGE using 6 M urea in the solution for the running gel. This pro-
cedure separates a- and ß-tubulin [17]. The a-tubulin containing gel 
fragments (upper band) were subjected to in situ fragmentation by 
CNBr, separated by SDS-PAGE and electrophoretically blotted 
onto a poly(vinylidenedifluoride) membrane. A CNBr fragment with 
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an apparent Μτ of 14000 was subjected to automated sequencing, 
which resolves the phenylthiohydantoin derivatives of lysine and 
7V-e-acetyl-lysine [1]. 
2.4. Immunoblotting 
SDS-PAGE of the cytoskeletal residue was performed in the pres-
ence of 6 M urea in the separation gel to separate a- and ß-tubulin. 
Corresponding blots were analyzed with the murine monoclonal anti-
body DM1A (Sigma, Deisenhofen, Germany), a general antibody for 
a-tubulins, and the murine monoclonal antibody GT 335 [25], kindly 
provided by Dr. B. Eddé. The second antibody was peroxidase-
labelled rabbit anti-mouse antibody (Dako, Hamburg, Germany). 
3. Results 
SDS-PAGE of Giardia cells extracted by Triton X-100 
showed that the cytoskeletal preparation is dominated by tu-
bulin and the lower molecular weight giardins [11,22,23,26]. 
Preparative SDS-PAGE was used to isolate the Giardia tubu-
lin. The Coomassie brilliant blue-stained tubulin band was 
excised and aliquote of the gel fragments were processed to 
isolate the carboxy-terminal peptides. 
3.1. Glycylated and glutamylated ß-tubulin variants 
After in situ treatment with CNBr the mixture of tubulin 
fragments was chromatographed on a small DEAE column. 
The various acidic peptides eluting late from the column were 
subjected to HPLC as described in Section 2. All peaks from 
the HPLC experiments were monitored by mass spectrometry 
and the major peaks were also subjected to automated Edman 
degradation. Fig. 1 summarizes the large number of variants 
of the carboxy-terminal ß-tubulin peptide. Its sequence of 31 
residues was established on a fraction containing essentially 
unmodified peptide and is given at the top of the figure. Ex-
cept for the last two residues this sequence fits the carboxy-
terminal sequence following methionine-415 predicted by 
cDNA cloning. The terminal sequence has been given as 
FGDE [27] and FGDEQ (accession number P05304) while 
we find FGDEYA by direct automated sequencing. Our se-
quence is independently supported by carboxypeptidase Y di-
gestion monitored by mass spectrometry. A time course ex-
periment shows that the terminal alanine (A) is preceded by 
tyrosine (Y). Lack of further digestion is in line with the 
preceding acidic residues. 
The major fractions of the ß-peptide are the unmodified 
form and the series of glycylated derivatives ranging from 
1 to 15 extra glycyl residues (Fig. 1). In this series of poly-
glycylated variants the main components have 8-12 extra 
glycyl residues. Less abundant variants show either 1 or 2 ad-
ditional glutamyl residues with or without 1-3 extra glycyl 
residues (Fig. 1С). These more acidic species eluted as the 
last peak from the DEAE column. We also observed a series 
of variants containing 6-12 extra glycyl residues in addition to 
a single extra glutamyl residue (Fig. ID). A rough estimate of 
the relative abundance based on the peak heights of the var-
ious HPLC chromatograms and the distribution observed by 
mass spectrometry indicates that the unmodified and the gly-
cylated series of peptides are the major components. The glu-
tamylated peptides and the peptides containing both modifi-
cations reflect minor species. 
3.2. Glycylated and glutamylated a-tubulin variants 
The carboxy-terminal α-tubulin variants were obtained 
from a digest of the tubulin band with the endoproteinase 
LysC separated on a Mono Q column. The various acidic 
peptide peaks eluting late from the anion exchange column 
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Fig. 1. Mass spectra of the carboxy-terminal peptides of Giardia ß-tubulin generated by CNBr cleavage. A: Mass spectrum of a fraction con-
taining the unmodified species (GO) and several glycylated components which are marked G1-G7 according to the number of additional glycyl 
residues. The amino acid sequence obtained by Edman degradation is given at the top. B: Fraction of the peptide showing higher levels of 
glycylation. The number of extra glycyl residues ranges from seven (G7) to 15 (G15). C: Mass spectrum of a fraction of the peptide in gluta-
mylated and glycylated form. The number of glutamyl residues is one or two (El, E2). Some species carry in addition 1-3 extra glycyl residues 
marked G1-G3. D: Peptide variants with one additional glutamyl residue (El) and 6-12 extra glycyl residues (G6-G12). The left part of the 
spectrum shows two variants with seven and eight glycyl residues only. 
К. Weber et al.lFEBS Letters 419 (1997) 87-91 
alpha DYEEIGAETLGDGEGEDMEEDDAY 
^Цм-л-
3000 2500 3000 3500 3000 3500 
Fig. 2. Mass spectra of the carboxy-terminal peptides of Giardia ce-tubulin generated by endoproteinase LysC. A: Mass spectrum of the un-
modified peptide (marked GO). The sequence obtained by Edman degradation is given at the top. The peak marked by a star has a mass incre-
ment of 16 corresponding to a fraction of the peptide in which the methionine residue was oxidized to the methionine sulf oxide. B: Fraction 
of the peptide containing several glutamylated components which are marked E1-E6 in addition to the unglutamylated form (EO). Stars are 
used as before. C: Mass spectrum of highly glycylated derivatives of the peptide labelled G2-G20 depending on the number of extra glycyl res-
idues. The stars mark the methionine sulfoxide form as above. GO is the non-glycylated peptide. 
were further analyzed by HPLC. All peaks from the HPLC 
experiments were monitored by mass spectrometry and the 
major peaks were also characterized by automated Edman 
degradation. Fig. 2 gives an overview of the large number 
of variants encountered. The sequence of 24 residues estab-
lished on a fraction containing essentially unmodified peptide 
(Fig. 2A) is given at the top of the figure. It fits a previous 
protein chemical study [11] and is additionally supported by a 
time course experiment with carboxypeptidase Y which proves 
that the final tyrosine residue is preceded by an alanine. Lack 
of further digestion is in line with the preceding cluster of 
acidic residues. 
The major fractions of the α-peptide are the unmodified 
form (Fig. 2A) and a series of glycylated derivatives ranging 
from 2 to 20 extra glycyl residues (Fig. 2C). In this series 
components with 13 and 14 glycyl residues are particularly 
abundant. The mass spectrum of a HPLC fraction originating 
from a Mono Q fraction which eluted at high salt is shown in 
Fig. 2B. It contains in addition to the unmodified peptide a 
series of variants with 1-6 extra glutamyl residues. These glu-
tamylated variants accounting for a minor fraction of the 
α-peptide were not detected in a previous analysis [11]. 
Because of technical difficulties with the amino acid se-
quencer and the limited amount of material available the po-
sition of the first glycylated residue in the sequences was not 
unambiguously identified. However, the available sequence 
data show that the modifications must lie in the last 10-14 
residues, i.e. in the region where they have been precisely 
mapped in certain axonemal tubulins [10,12-16]. 
3.3. Immunological detection of glutamylated a- and ß-tubulins 
Immunological evidence for glutamylation of Giardia tubu-
lins comes also from the reactivity of the glutamylation-spe-
cific tubulin antibody GT335 [25] in immunoblotting experi-
ments (Fig. 3). This monoclonal antibody detects both a- and 
ß-tubulin. 
3.4. Extensive acetylation of Lys-40 of cytoskeletal a-tubulin 
The degree of acetylation of Lys-40 in α-tubulin is easily 
monitored when a CNBr digest is separated by SDS-PAGE, 
blotted onto a poly(vinylidenedifluoride) membrane and the 
individual bands subjected to automated sequencing [1,17]. 
Fig. 4 shows the amino-terminal sequence of a large Giardia 
CNBr fragment and its alignment versus the corresponding 
Fig. 3. Detection of glutamylated tubulin variants in immunoblot-
ting with monoclonal antibody GT335. An aliquot of the cytoskele-
tal residue was used in SDS-PAGE using conditions which allow 
separation of a- and ß-tubulin (see Section 2). Parallel immunoblots 
were processed with the general a-tubulin antibody DM1A, which 
stains the upper α-band, and with the glutamylation-specific anti-
body GT335, which detects both the a- and ß-tubulin bands. 
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Fig. 4. Acetylation site of α-tubulin from Giardia lamblia. The 
upper line gives the amino-terminal sequence of the large CNBr 
fragment of Giardia (Giar) α-tubulin (Afr 14000). At the fourth step 
only the phenylthiohydantoin of TV-e-acetyl-lysine was found (Ace-
tyl-K in the sequence). The lower line gives the corresponding re-
gion and residue numbers of Trypanosoma (Tryp) a-tubulin pre-
dicted from the cDNA sequence [35]. Note the two amino acid 
exchanges at positions 44 and 45. 
Trypanosoma sequence. At the fourth step corresponding to 
residue 40 only JV-acetyl-lysine was detected. Thus Lys-40 
seems completely acetylated. 
4. Discussion 
Tubulins from the stable microtubules retained in cytoske-
letal preparations of Giardia lamblia were analyzed for post-
translational modifications. Mass spectrometry and sequence 
analysis of the isolated carboxy-terminal peptides were used to 
monitor the tubulin specific modifications which locate to this 
region (for references see Section 1). The major variants of 
both ß- and a-tubulin are the unmodified polypeptides and a 
series of polyglycylated derivatives reaching up to 15 and 20 
extra residues respectively. Thus polyglycylation is the major 
tubulin-specific modification in Giardia lamblia (Figs. 1 and 
2). Polyglutamylation, a second tubulin-specific modification, 
was only encountered as a minor fraction and with rather 
short side lengths. Up to two extra glutamyl residues were 
encountered in ß-tubulin while in a-tubulin the maximal num-
ber observed was six. Some of the glutamylated ß-tubulin 
variants were additionally glycylated by 1-12 glycyl residues. 
Modification of the same tubulin molecules by glycylation and 
glutamylation was also found in sperm axonemes of sea ur-
chin and bull [12-14,16] where it also reflects minor species. In 
all these cases the number of extra glutamyl residues is low 
while glycylation can reach higher values (see also Fig. 1). 
A previous study of Giardia a-tubulin concentrating on 
polyglycylation did not resolve the issue of a possible tubulin 
glutamylation [11]. To answer this question unambiguously 
we analyzed both a- and ß-tubulin and monitored each 
peak of the anion exchange columns by HPLC and mass 
spectrometry. In addition we had access to the monoclonal 
antibody GT335, which detects glutamylated α-tubulins and 
some glutamylated ß-tubulins. The antibody requires a gluta-
mylation motif already provided by monoglutamylated a-tu-
bulin and certain sequence elements around the glutamylation 
site. Thus its reactivity is independent of the degree of gluta-
mylation beyond the first side chain residue [25]. Its reactivity 
on both a- and ß-tubulin of Giardia cytoskeletons fully con-
firms the mass spectroscopic results on the carboxy-terminal 
peptides. In addition the immunoblot in Fig. 3 shows that in 
comparison to the general antibody for a-tubulin the gluta-
mylated variants must be minor components as also seen in 
the mass spectroscopic results. 
Giardia lamblia lacks the detyrosination/tyrosination cycle. 
All of the many variants of the carboxy-terminal peptide of 
a-tubulin retain the terminal tyrosine indicative of the absence 
of a tubulin carboxypeptidase. In addition the terminal se-
quence DAY would not be accepted in detyrosinated form 
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by tubulin tyrosine ligase. At least the mammalian enzyme 
adds the tyrosine only to a terminal glutamic acid and 
strongly prefers a penultimate glutamic acid [8]. Such a se-
quence, EEY, is found in a-tubulin from Trypanosoma, which 
is known to have a detyrosination/tyrosination cycle 
[17,28,29]. We also monitored the only tubulin modification 
outside the carboxy-terminal region. A previous immunoelec-
tron microscopic study with a monoclonal antibody to acetyl-
ated a-tubulin [30] detected axonemal and cytoplasmic micro-
tubules of Giardia. Our results confirm and quantitate these 
results. Automated sequencing of a corresponding CNBr frag-
ment of a-tubulin shows that Lys-40 is fully acetylated 
(Fig. 4). 
Ribosomal RNA and various protein phylogenies [18-21] 
suggest that Giardia lamblia reflects the oldest branch of the 
eukaryotic tree. Our results document that this ancient eukar-
yote has already nearly the entire complement of tubulin-spe-
cific posttranslational modifications established for other 
eukaryotes. Giardia lamblia shows polyglycylation and poly-
glutamylation of both a- and ß-tubulin and the acetylation of 
a-tubulin. However, it lacks the detyrosination/tyrosination 
cycle of a-tubulin, which is already present in Trypanosoma 
[17,28,29], a somewhat younger branch of the eukaryotic tree. 
Polyglycylation has so far only been observed in axonemal 
microtubules [10-16] but the lack of this modification in the 
flagellum of Trypanosoma brucei shows that polyglycylation is 
not a necessary requirement of axonemal structure [17]. Thus 
glutamylation is particularly interesting since it is present on 
microtubules from a wide variety of organisms including ani-
mals, ciliates, Trypanosoma and green algae [17,25,31-33] as 
well as Giardia. Its function seems to involve a regulation of 
the affinity of tubulin for certain microtubule-associated pro-
teins [34]. 
References 
[1] LeDizet, M. and Piperno, G. (1987) Proc. Nati. Acad. Sci. USA 
84, 5720-5724. 
[2] Luduena, R.F., Zimmermann, H.S. and Little, M. (1988) FEBS 
Lett. 230, 142-146. 
[3] Diaz-Nido, J., Serrano, L., Lopez-Otin, C, Vandekerckhove, J. 
and Avila, J. (1990) J. Biol. Chem. 265, 13949-13954. 
[4] Rüdiger, M. and Weber, K. (1993) Eur. J. Biochem. 218, 107-
116. 
[5] Barra, H.S., Rodriguez, J.A., Arce, CA. and Caputto, R. (1973) 
J. Neurochem. 20, 97-108. 
[6] Ersfeld, K., Wehland, J., Plessmann, U., Dodemont, H., Gerke, 
V. and Weber, K. (1993) J. Cell Biol. 120, 725-732. 
[7] Paturle-Lafanchére, L., Eddé, В., Denoulet, P., Van Dorsselaer, 
A., Mazarguil, A., Le Caer, J.-P., Wehland, J. and Job, D. (1991) 
Biochemistry 30, 10523-10528. 
[8] Rüdiger, M., Wehland, J. and Weber, K. (1994) Eur. J. Biochem. 
220, 309-320. 
[9] Eddé, В., Rossier, J., Le Caer, J.-P., Desbruyéres, E., Gros, F. 
and Denoulet, P. (1990) Science 247, 83-84. 
[10] Redeker, V., Levilliers, N., Schmitter, J.-M., Le Caer, J.-P., 
Rossier, J., Adoutte, A. and Bré, M.H. (1994) Science 266, 
1688-1691. 
[11] Weber, K., Schneider, A., Müller, N. and Plessmann, U. (1996) 
FEBS Lett. 393, 27-30. 
[12] Multigner, L., Pignot-Paintrand, I., Saoudi, Y., Job, D., Pless-
mann, U., Rüdiger, M. and Weber, K. (1996) Biochemistry 33, 
10862-10871. 
[13] Mary, J., Redeker, V., Le Caer, J.-P., Rossier, J. and Schmitter, 
J.M. (1996) J. Biol. Chem. 270, 9928-9933. 
[14] Mary, J., Redeker, V., Le Caer, J.-P., Rossier, J. and Schmitter, 
J.M. (1997) J. Protein Chem. 16, 403^107. 
К. Weber et al.lFEBS Letters 419 (1997) 87-91 
[15] Rüdiger, M., Plessmann, U., Rüdiger, A.-H. and Weber, K. 
(1995) FEBS Lett. 364, 147-151. 
[16] Plessmann, U. and Weber, K. (1997) J. Protein Chem. 16, 385-
390. 
[17] Schneider, A., Plessmann, U. and Weber, K. (1997) J. Celi Sci. 
ПО, 431^137. 
[18] Sogin, M.L., Gunderson, J.H., Elwood, HJ . , Alonso, R.A. and 
Peattie, D.A. (1989) Science 243, 75-77. 
[19] Drouin, G., de Sa, M.M. and Zuker, M. (1995) J. Mol. Evol. 41, 
841-849. 
[20] Keeling, P.J. and Doolittle, W.F. (1996) J. Mol. Evol. 13, 1297-
1305. 
[21] Yamamoto, A., Hashimoto, Т., Asaga, E., Hasegawa, M. and 
Goto, N. (1997) J. Mol. Evol. 44, 98-105. 
[22] Holberton, D.V. (1981) J. Cell Sci. 47, 167-185. 
[23] Holberton, D.V. and Ward, A.P. (1981) J. Cell Sci. 47, 139-166. 
[24] Bonetto, V., Bergman, A.C., Jornvall, H. and Sillard, R. (1997) 
J. Protein Chem. 16, 371-374. 
[25] Wolff, A., de Néchaud, В., Chillet, D., Mazarguil, H., Des-
bruyéres, E., Audebert, S., Eddé, В., Gros, F. and Denoulet, P. 
(1992) Eur. J. Cell Biol. 59, 425^132. 
91 
[26] Crossley, R. and Holberton, D.V. (1983) J. Cell Sci. 59, 81-103. 
[27] Kirk-Mason, K.E., Turner, M.J. and Chakraborty, P.R. (1988) 
Nucleic Acids Res. 16, 2733. 
[28] Schneider, A., Sherwin, Т., Sasse, R., Russell, D.G., Gull, K. and 
Seebeck, T. (1987) J. Cell Biol. 104, 431^138. 
[29] Sherwin, Т., Schneider, A., Sasse, R., Seebeck, T. and Gull, K. 
(1987) J. Cell Biol. 104, 439^146. 
[30] Soltys, B.J. and Gupta, R.S. (1994) J. Eukaryote Microbiol. 41, 
625-632. 
[31] Bré, M.H., de Nechaud, В., Wolff, A. and Fleury, A. (1995) Cell 
Motil. Cytoskeleton 27, 337-349. 
[32] Levilliers, N., Fleury, A. and Hill, A.-H. (1995) J. Cell Sci. 108, 
3013-3028. 
[33] Geimer, S., Teltenkötter, A., Plessmann, U., Weber, K. and 
Lechtreck, K.F. (1997) Cell Motil. Cytoskeleton 36, 1-14. 
[34] Boucher, D., Larcher, J.C., Gros, F. and Denoulet, P. (1994) 
Biochemistry 33, 12471-12477. 
[35] Kimmel, B.E., Samson, S., Wu, J., Hirschberg, R. and Yar-
brough, L.R. (1985) Gene 35, 237-248. 
